Chandra Belani

University Of Pittsburgh At Pittsburgh

$1,686,281

Attributed

$1,686,281

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $428.5K · FY2005–09

$500K$375K$250K$125K$0

'05

'06

'07

'08

'09

Funding mix

By agency

NIH$1,686,281 · 7

By mechanism

U01$1,672,355 · 1

M01$13,926 · 6

Top collaborators

No co-investigators on record.

Most similar at University Of Pittsburgh At Pittsburgh

Same institution · by research overlap

Reza Zarnegar$10,558,814
Candace S Johnson$18,922,226
Jaideep Behari$4,660,334
Robert S. Clark$12,893,742
George K Michalopoulos$12,892,897

Others in their field

Top investigators on “Clinical Research”

David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
Sonia M Thomas · Research Triangle Institute$700,865,642
Jeffrey P Krischer · University Of South Florida$611,867,176
Barton F Haynes · Duke University$538,862,577

Research focus

Clinical ResearchClinical Trial Phase IHuman SubjectHuman Therapy EvaluationDrug Screening /EvaluationNeoplasm /Cancer ChemotherapyDrug Administration Rate /DurationPharmacokineticsPaclitaxelDrug InteractionsColony Stimulating FactorDrug Adverse EffectCombination ChemotherapyCarboplatinNonsmall Cell Lung CancerDrug Administration RoutesNeutrophilP53 Gene /ProteinHematopoietic Stem CellsHepatocellular CarcinomaNeoplasm /Cancer ImmunotherapyCis Platinum CompoundAdenoviridaeGene Therapy